Envista Holdings is trading 4% down at $24.75, amid broad market weakness, elevated Treasury yields, and renewed inflation concerns tied to surging energy prices.
- Its September 15 conference presentation highlighted China-related channel inventory pressure and a likely third-quarter decline.
- It maintained full-year 2026 guidance and did not explicitly link those comments to the share decline.
- Healthcare is outperforming the broader market; the 10-year Treasury yield reached 5.02% as investors positioned ahead of the Federal Reserve decision.